IN BRIEF: SkinBioTherapeutics unaware of reason for share price drop
SkinBioTherapeutics PLC- Skin health-focused life sciences company - Says it is not aware of any "material commercial or operational" reason for the fall in its share price on Monday. Adds that it continues to focus on driving sales of its AxisBiotix-Ps probiotic food supplement, which holds a subscriber-retention rate of more than 80%. Read More